Theranos Founder Elizabeth Holmes Is on Trial. Silicon Valley Is Watching

Theranos Founder Elizabeth Holmes Is on Trial. Silicon Valley Is Watching

Six pages of text messages are some of the first documents to come out of Holmes’ trial, which began this week, more than three years after she was indicted on charges of defrauding investors , as well as doctors and patients, about Theranos’ capabilities.

A New Look Inside Theranos’ Dysfunctional Corporate Culture

A New Look Inside Theranos’ Dysfunctional Corporate Culture

Patel was the biochemist who led the development of blood tests for Theranos’s new device, which Beam knew only by its code name—“4S.” Patel let slip that his team was still developing its assays on lab plates on the bench.

The Other Big Lesson We Should Learn From Theranos

The Other Big Lesson We Should Learn From Theranos

The business-friendly government was eager to nurture a Silicon Valley in Arizona and quickly paved the way for the company’s “miracle technology,” which purported to perform cheap medical tests from a single drop of blood.

'The Inventor,' Theranos, and Multiplatform Schadenfreude

'The Inventor,' Theranos, and Multiplatform Schadenfreude

HBO Over the course of 119 minutes in The Inventor: Out for Blood in Silicon Valley , Alex Gibney's new documentary about Elizabeth Holmes and Theranos, very little is made of Holmes' speaking voice.

Elizabeth Holmes’ Downfall Has Been Explained Deeply—By Men

Elizabeth Holmes’ Downfall Has Been Explained Deeply—By Men

Elizabeth Holmes’ Downfall Has Been Explained Deeply—By Men Brendan McDermid/Reuters Maybe Elizabeth Holmes, whom a grand jury indicted last month for fraud, never should have asked herself, “What would you do if you knew you could not fail?” 1 The eye-roller slogan adorned a plaque on Holmes’ desk at Theranos, her ignoble blood-testing startup.

11 Fantastic Science Books to Binge Over the Holidays

11 Fantastic Science Books to Binge Over the Holidays

[ Amazon ] —Robbie Gonzales Knopf John Carreyrou, Bad Blood The astonishing thing about Elizabeth Holmes, the Stanford dropout who raised $1.4 billion to start the blood-testing company Theranos, was how badly the people in her orbit wanted to believe her story.